What is the appropriate prazosin dosing regimen for a teenager, including starting dose, titration schedule, maximum dose, and considerations for treating nightmares or hypertension?

Prazosin Dosing for Teenagers

For teenagers with PTSD-related nightmares, start prazosin at 1 mg at bedtime, titrate gradually by 1 mg every 3-7 days based on response and tolerability, with typical effective doses ranging from 2-6 mg nightly (maximum 15 mg), while monitoring for orthostatic hypotension especially after the first dose.

Clinical Context and Evidence Base

The evidence for prazosin in adolescents comes primarily from pediatric case series and retrospective reviews, as the major guideline evidence addresses adults 1. However, the FDA labeling provides the foundational dosing framework 2, and pediatric studies demonstrate safety and efficacy at lower doses than adults.

Specific Dosing Algorithm for Nightmares/PTSD

Starting Dose

• Begin with 1 mg at bedtime 2, 3, 4
• This conservative start minimizes first-dose hypotension risk, which is the primary safety concern

Titration Schedule

• Increase by 1 mg every 3-7 days based on:
  • Nightmare frequency and severity reduction
  • Tolerability (dizziness, orthostatic symptoms)
  • Blood pressure monitoring
• The pediatric literature shows a dose range of 1-15 mg at bedtime (0.02-0.3 mg/kg) 3

Target Maintenance Dose

• Most adolescents respond to 2-6 mg nightly 3, 4, 5
• 35% of pediatric patients in one series required ≥5 mg/day 3
• Case reports document effective doses of 1-4 mg/day in younger patients 4

Maximum Dose

• 15 mg at bedtime appears to be the upper limit documented in adolescents 3
• Adult studies used higher doses (15.6 mg in men, 7.0 mg in women) 1, but adolescents typically respond at lower doses

Critical Safety Monitoring

First-Dose Precautions

• Monitor blood pressure 2-3 hours after the first dose 2
• Counsel patient to take at bedtime when already lying down
• Warn about potential dizziness upon standing

Ongoing Monitoring

• Blood pressure at each titration visit
• Assess for orthostatic symptoms (18% experience dizziness in pediatric series) 3
• Monitor for headaches (6%) and anxiety (9%) 3

Common Pitfalls to Avoid

1. Titrating too rapidly: This increases orthostatic hypotension risk
2. Inadequate trial duration: Allow 2-4 weeks at each dose to assess efficacy before increasing
3. Ignoring concurrent medications: SSRIs may reduce prazosin response 1
4. Stopping abruptly: Nightmares frequently return to baseline when discontinued 1

Hypertension Dosing (If Applicable)

While prazosin is FDA-approved for hypertension 2, this is rarely the primary indication in adolescents. If treating hypertension:

• Start 1 mg 2-3 times daily 2
• Titrate slowly to total daily dose of 6-15 mg in divided doses 2
• Maximum 40 mg/day (though doses >20 mg rarely add benefit) 2
• The 2017 AAP hypertension guideline recommends ACE inhibitors, ARBs, calcium channel blockers, or thiazide diuretics as first-line agents—not prazosin 6

Evidence Quality Considerations

Important nuance: The adult nightmare literature shows mixed results. While multiple RCTs demonstrated efficacy 1, a large 2018 VA study of 304 patients found no benefit over placebo 1. The guideline task force downgraded their recommendation but noted "many patients respond very well to prazosin and this agent remains the first choice for pharmacologic therapy" 1. The negative study had 78% of patients on concurrent antidepressants, which may explain the lack of effect 1.

The pediatric evidence is weaker (case series and retrospective reviews) but consistently positive. A 2017 retrospective review of 34 youth showed 79% improvement in sleep/nightmares (pre-treatment score 7.3, post-treatment 3.1, p<0.001) 3. Treatment-emergent side effects occurred in 26% but were generally mild 3.

Practical Implementation

Week-by-week approach:

• Week 1: 1 mg at bedtime, monitor BP after first dose
• Week 2: If tolerated, increase to 2 mg
• Week 3-4: Assess response; if inadequate and well-tolerated, increase to 3 mg
• Continue titrating by 1 mg every 1-2 weeks until nightmares resolve or side effects emerge
• Most adolescents stabilize at 3-6 mg nightly

When to stop titrating:

• Nightmares significantly reduced (>50% improvement)
• Orthostatic symptoms develop
• Maximum dose of 15 mg reached without benefit

This dosing strategy balances the FDA-approved adult framework 2 with pediatric-specific evidence 3, 4 while prioritizing safety through gradual titration and close monitoring.